Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | BMY | AMGN | GILD | MRNA |
| Company | Eidos Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 127.57 | 43.56 | 309.53 | 65.18 | 123.15 |
| High | 128.49 | 44.81 | 314.60 | 65.22 | 125.50 |
| Low | 116.83 | 43.49 | 306.32 | 64.52 | 121.68 |
| Last | 122.21 | 44.74 | 312.86 | 64.58 | 122.69 |
| Change | -6.23 | +1.07 | +5.55 | -0.34 | +0.80 |
| % Change | -4.85% | +2.45% | +1.81% | -0.52% | +0.66% |
| Volume | 335,500 | 10,776,300 | 2,921,300 | 6,048,500 | 3,367,300 |
| 20-Day Average Volume | 113,985 | 14,356,360 | 2,907,275 | 7,462,300 | 3,313,220 |
| Previous Close | 128.44 | 43.67 | 307.31 | 64.92 | 121.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 46.17 | 279.47 | 66.10 | 111.34 |
| 20-Day Raw Stochastic | 36.63% | 22.60% | 84.27% | 5.83% | 79.26% |
| 20-Day Relative Strength | 56.42% | 35.71% | 68.03% | 31.74% | 64.26% |
| Weighted Alpha | +136.62 | -34.69 | +35.65 | -21.62 | +9.94 |
| Today's Opinion | 88% Buy | 100% Sell | 56% Buy | 100% Sell | 100% Buy |
| Previous Opinion | 100% Buy | 100% Sell | 56% Buy | 100% Sell | 100% Buy |
| Last Month's Opinion | 100% Buy | 48% Sell | 40% Sell | 100% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | +2.38% since 05/02/24 | +12.38% since 05/02/24 | -1.15% since 05/02/24 | -2.31% since 05/02/24 |
| Low | 116.83 on 01/25/21 | 43.49 on 05/09/24 | 297.52 on 05/06/24 | 64.33 on 05/03/24 | 118.68 on 05/07/24 |
| High | 131.08 on 01/20/21 | 44.81 on 05/09/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 126.40 on 05/03/24 |
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | -13.29% since 04/09/24 | +15.72% since 04/09/24 | -7.66% since 04/09/24 | +9.94% since 04/09/24 |
| Low | 116.24 on 01/05/21 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 99.30 on 04/22/24 |
| High | 132.54 on 01/04/21 | 51.28 on 04/10/24 | 322.60 on 05/03/24 | 69.76 on 04/10/24 | 128.81 on 05/02/24 |
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | -10.18% since 02/09/24 | +7.47% since 02/09/24 | -12.34% since 02/09/24 | +40.36% since 02/09/24 |
| Low | 69.38 on 10/30/20 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 84.06 on 02/13/24 |
| High | 132.54 on 01/04/21 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 128.81 on 05/02/24 |
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | -11.25% since 11/09/23 | +18.48% since 11/09/23 | -13.87% since 11/09/23 | +76.51% since 11/09/23 |
| Low | 38.44 on 07/31/20 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 67.62 on 11/13/23 |
| High | 132.54 on 01/04/21 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 128.81 on 05/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 88,523,448 | 164,851,840 | 80,830,400 | 46,713,120 |
| Shares Outstanding, K | 38,873 | 2,027,100 | 536,435 | 1,245,077 | 383,240 |
| Annual Sales | 26,690,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -37,840,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 130,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 | 167,000,000 |
| Last Quarter Net Income | -30,180,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 | -1,175,000,000 |
| 60-Month Beta | -0.16 | 0.45 | 0.60 | 0.22 | 1.57 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | -3.07 on 05/02/24 |
| Latest Earnings Date | 02/24/21 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.94 | 16.12 | 16.24 | 0.00 |